A5049588882- Acute Ischemic Stroke Management
- Advanced MRI Techniques and Applications
- Cerebrovascular and Carotid Artery Diseases
- Vestibular and auditory disorders
- Intracranial Aneurysms: Treatment and Complications
- Glaucoma and retinal disorders
- EEG and Brain-Computer Interfaces
- Stroke Rehabilitation and Recovery
- Functional Brain Connectivity Studies
- Myasthenia Gravis and Thymoma
- Uterine Myomas and Treatments
- Ocular Surface and Contact Lens
- Advanced Neuroimaging Techniques and Applications
- Neurosurgical Procedures and Complications
- Ophthalmology and Eye Disorders
- Head and Neck Surgical Oncology
- Aortic Disease and Treatment Approaches
- Blood Pressure and Hypertension Studies
- Meningioma and schwannoma management
- Peripheral Nerve Disorders
- Traumatic Brain Injury and Neurovascular Disturbances
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Valve Diseases and Treatments
- Neurological Disease Mechanisms and Treatments
- Lanthanide and Transition Metal Complexes
Universitätsmedizin Göttingen
2024
Centre Hospitalier Universitaire de Grenoble
2012-2020
Inserm
2015-2020
Centre National de la Recherche Scientifique
2015-2020
Université Grenoble Alpes
2015-2020
Grenoble Institute of Neurosciences
2017
Commissariat à l'Énergie Atomique et aux Énergies Alternatives
2016
Clinatec
2016
CEA LETI
2016
CEA Grenoble
2016
The use of radiosensitizing nanoparticles with both imaging and therapeutic properties on the same nano-object is regarded as a major promising approach to improve effectiveness radiotherapy. Here, we report MRI findings phase 1 clinical trial single intravenous administration Gd-based AGuIX nanoparticles, conducted in 15 patients four types brain metastases (melanoma, lung, colon, breast). were found accumulate increase image contrast all enhancements equivalent that clinically used agent....
Myomas are benign uterine tumours found in 40-70% of women reproductive age. About 30% them cause various ailments (bleeding, pain, infertility) that reduce the quality women’s life. Uterine fibromas 40-60% hysterectomies. Different treatment methods used depending on size, number, location myomas and patient's preferences. Conservative includes nonsteroidal anti-inflammatory drugs, hormonal therapies as contraceptives, GnRH agonists or antagonists, selective progesterone receptor modulators...